Description
Introducing Skinceutical’s Triple Lipid Restore 2:4:2, a revolutionary anti-aging cream meticulously formulated to replenish cellular lipids and deeply nourish dry, dehydrated skin. Patented with U.S. Patent No. 10,137,073, this innovative cream is designed to address concerns of aging and dehydration with precision, making it suitable for all skin types, including dry, normal, oily, combination, and sensitive.
Crafted with an optimal and patented lipid ratio of 2% pure ceramides 1 and 3, 4% natural cholesterol, and 2% fatty acids, Triple Lipid Restore 2:4:2 delivers a potent blend of essential nutrients to the skin, effectively correcting signs of aging and restoring vitality. This unique lipid correction cream features the first 2:4:2 cholesterol-dominant ratio, which works synergistically to fortify the skin’s external barrier, support natural self-repair processes, and nourish aging skin from within.
Experience the transformative benefits of Triple Lipid Restore 2:4:2:
- Restores essential skin lipids, including ceramides, natural cholesterol, and fatty acids, promoting hydration and suppleness
- Improves the look of skin fullness, texture, and pore appearance, unveiling a smoother, more refined complexion
- Enhances the appearance of skin evenness and overall radiance, restoring youthful luminosity
- Features a unique lipid stabilization system in a lightweight, fast-absorbing texture, ensuring effortless application and maximum efficacy
- Shortens the adjustment period to retinoids by up to 1 week while reducing dryness, offering comfort and convenience during skincare transitions
- Free from parabens and dyes, Triple Lipid Restore 2:4:2 is gentle and safe for aging, normal, and dry skin types
TSA-approved for your convenience, Triple Lipid Restore 2:4:2 is your trusted companion for achieving hydrated, rejuvenated skin wherever your travels take you. Embrace the power of patented lipid technology and unlock the secret to youthful vitality with Triple Lipid Restore 2:4:2.
Reviews
There are no reviews yet.